Axsome Therapeutics Shares Hit 52-Week Low as Much as 15%
Axsome shares fell as much as 15% on Monday as investors focused on Auvelity launch pacing in Alzheimer’s disease agitation, despite the company’s strong third-quarter report.
Shares of Axsome Therapeutics (AXSM) fell as much as 15% on Monday to a new 52-week low as investors focused on Auvelity's launch pacing in the Alzheimer’s disease agitation (ADA) indication, despite the company’s strong third-quarter report.Auvelity, the company’s key drug, was first approved for…